BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28177086)

  • 1. Lessons learned from a multidisciplinary renal genetics clinic.
    Alkanderi S; Yates LM; Johnson SA; Sayer JA
    QJM; 2017 Jul; 110(7):453-457. PubMed ID: 28177086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.
    Pierides A; Voskarides K; Athanasiou Y; Ioannou K; Damianou L; Arsali M; Zavros M; Pierides M; Vargemezis V; Patsias C; Zouvani I; Elia A; Kyriacou K; Deltas C
    Nephrol Dial Transplant; 2009 Sep; 24(9):2721-9. PubMed ID: 19357112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and diagnostic utility of genomic sequencing for children referred to a Kidney Genomics Clinic with microscopic haematuria.
    Shanks J; Butler G; Cheng D; Jayasinghe K; Quinlan C
    Pediatr Nephrol; 2023 Aug; 38(8):2623-2630. PubMed ID: 36715773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot Study of Return of Genetic Results to Patients in Adult Nephrology.
    Nestor JG; Marasa M; Milo-Rasouly H; Groopman EE; Husain SA; Mohan S; Fernandez H; Aggarwal VS; Ahram DF; Vena N; Bogyo K; Bomback AS; Radhakrishnan J; Appel GB; Ahn W; Cohen DJ; Canetta PA; Dube GK; Rao MK; Morris HK; Crew RJ; Sanna-Cherchi S; Kiryluk K; Gharavi AG
    Clin J Am Soc Nephrol; 2020 May; 15(5):651-664. PubMed ID: 32299846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-sectional study of patients referred for HNF1B-MODY genetic testing due to cystic kidneys and diabetes.
    Sztromwasser P; Michalak A; Małachowska B; Młudzik P; Antosik K; Hogendorf A; Zmysłowska A; Borowiec M; Młynarski W; Fendler W
    Pediatr Diabetes; 2020 May; 21(3):422-430. PubMed ID: 31825128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.
    Nabais Sá MJ; Storey H; Flinter F; Nagel M; Sampaio S; Castro R; Araújo JA; Gaspar MA; Soares C; Oliveira A; Henriques AC; da Costa AG; Abreu CP; Ponce P; Alves R; Pinho L; Silva SE; de Moura CP; Mendonça L; Carvalho F; Pestana M; Alves S; Carvalho F; Oliveira JP
    Clin Genet; 2015 Nov; 88(5):456-61. PubMed ID: 25307543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic mutational testing of Chinese children with familial hematuria with biopsy‑proven FSGS.
    Li Y; Wang Y; He Q; Dang X; Cao Y; Wu X; Mo S; He X; Yi Z
    Mol Med Rep; 2018 Jan; 17(1):1513-1526. PubMed ID: 29138824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families.
    Endreffy E; Ondrik Z; Iványi B; Maróti Z; Bereczki C; Haszon I; Györke Z; Worum E; Németh K; Rikker C; Ökrös Z; Túri S
    Mol Cell Probes; 2011 Feb; 25(1):28-34. PubMed ID: 20951199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and acceptability of providing nurse counsellor genetics clinics in primary care.
    Westwood G; Pickering RM; Latter S; Lucassen A; Little P; Karen Temple I
    J Adv Nurs; 2006 Mar; 53(5):591-604. PubMed ID: 16499680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
    Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
    Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members.
    Savige J
    Pediatr Nephrol; 2020 Jan; 35(1):59-66. PubMed ID: 30506145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Informing a value care model: lessons from an integrated adult neurogenomics clinic.
    McLean A; Tchan M; Devery S; Smyth R; Shrestha R; Kumar KR; Tomlinson S; Tisch S; Wu KHC
    Intern Med J; 2023 Dec; 53(12):2198-2207. PubMed ID: 37092903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.
    Papazachariou L; Papagregoriou G; Hadjipanagi D; Demosthenous P; Voskarides K; Koutsofti C; Stylianou K; Ioannou P; Xydakis D; Tzanakis I; Papadaki A; Kallivretakis N; Nikolakakis N; Perysinaki G; Gale DP; Diamantopoulos A; Goudas P; Goumenos D; Soloukides A; Boletis I; Melexopoulou C; Georgaki E; Frysira E; Komianou F; Grekas D; Paliouras C; Alivanis P; Vergoulas G; Pierides A; Daphnis E; Deltas C
    Clin Genet; 2017 Nov; 92(5):517-527. PubMed ID: 28632965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.
    Weber S; Strasser K; Rath S; Kittke A; Beicht S; Alberer M; Lange-Sperandio B; Hoyer PF; Benz MR; Ponsel S; Weber LT; Klein HG; Hoefele J
    Pediatr Nephrol; 2016 Jun; 31(6):941-55. PubMed ID: 26809805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.
    Stratton KL; Alanee S; Glogowski EA; Schrader KA; Rau-Murthy R; Klein R; Russo P; Coleman J; Offit K
    Urol Oncol; 2016 May; 34(5):238.e1-7. PubMed ID: 26723226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COL4A4-related nephropathy caused by a novel mutation in a large consanguineous Saudi family.
    Ramzan K; Imtiaz F; Taibah K; Alnufiee S; Akhtar M; Al-Hazzaa SA; Al-Owain M
    Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):427-32. PubMed ID: 24398087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group.
    Frascà GM; Onetti-Muda A; Mari F; Longo I; Scala E; Pescucci C; Roccatello D; Alpa M; Coppo R; Li Volti G; Feriozzi S; Bergesio F; Schena FP; Renieri A;
    Nephrol Dial Transplant; 2005 Mar; 20(3):545-51. PubMed ID: 15618242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A5 mutations and clinical characterization of 22 families.
    Nabais Sá MJ; Sampaio S; Oliveira A; Alves S; Moura CP; Silva SE; Castro R; Araújo JA; Rodrigues M; Neves F; Seabra J; Soares C; Gaspar MA; Tavares I; Freitas L; Sousa TC; Henriques AC; Costa FT; Morgado E; Sousa FT; Sousa JP; da Costa AG; Filipe R; Garrido J; Montalban J; Ponce P; Alves R; Faria B; Carvalho MF; Pestana M; Carvalho F; Oliveira JP
    Clin Genet; 2015 Nov; 88(5):462-7. PubMed ID: 25307721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy.
    Voskarides K; Damianou L; Neocleous V; Zouvani I; Christodoulidou S; Hadjiconstantinou V; Ioannou K; Athanasiou Y; Patsias C; Alexopoulos E; Pierides A; Kyriacou K; Deltas C
    J Am Soc Nephrol; 2007 Nov; 18(11):3004-16. PubMed ID: 17942953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.